Fraternale, A., Paoletti, M
113: 7583, doi: Borst SE, Vincent KR, Lowenthal DT, Braith RW
Building stronger bones for the long haul Its not just about muscles
Blue Cross Blue Shield of Massachusetts and Point32Health are discontinuing coverage of GLP-1 medications for weight loss, and CVS Caremark has restricted its formulary to Wegovy, removing Zepbound
Enrollment duration Enrollment is usually valid for 12 months, with the exception of those enrolled in Medicare
Introduction Neurobehavioral and metabolic effects of GLP-1 RAs How GLP-1 RAs affect appetite Changes in cravings, mood, and behavior How GLP-1 drugs may reshape addiction pathways Clinical and public health implications Conclusions References Further reading The widely used obesity and diabetes GLP-1 drugs may do far more than reduce weight